natgillin/translations-raw huggingface dataset:
Very commonly reported side effects (at least 1 in every 10 patients): pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, stomach or abdominal pains, diarrhoea, nausea (feeling sick), viral infection, depression, emotional lability, insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
Zelo pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 10 bolnikov): bolečine, otekanje in pordelost ali poškodbe kože na mestu injiciranja, izpadanje las, omotica, sprememba teka, želodčne ali trebušne bolečine, driska, slabost (siljenje na bruhanje), virusne okužbe, depresija, čustvena nestabilnost, nespečnost, tesnoba, vnetje žrela in bolečine pri požiranju, utrujenost, mrzlica/ tresavica, zvišana telesna temperatura, gripi podobno stanje, splošni občutek neugodja, glavoboli, hujšanje, bruhanje, razdražljivost, šibkost, nihanje razpoloženja, kašelj (včasih hud), težko dihanje, srbenje, suha koža, izpuščaj, nenadne in hude mišične bolečine, sklepne bolečine, mišičnoskeletne bolečine, spremembe izvidov laboratorijskih krvnih preiskav vključno z 438 zmanjšanim številom belih krvničk.
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of  423 liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
Pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 100 bolnikov, vendar manj kot 1 na vsakih 10 bolnikov): žeja, dehidracija, zvišan krvni tlak, migrene, otekle bezgavke, pordelost, težave z menstruacijo, zmanjšana spolna sla, vaginalne težave, bolečine v dojkah, bolečine v modih, težave z žlezo ščitnico, pordele dlesni, suha usta, pordela ali vneta usta ali jezik, zobobol ali zobne bolezni, herpes simpleks (vročinske razjede), sprememba okusa, želodčne težave, dispepsija (zgaga), zaprtje, povečanje jeter (jetrne težave, včasih hude), vodeno blato, močenje postelje pri otrocih, vnetje sinusov, bronhitis, očesne bolečine, težave s solznimi kanalčki, konjunktivitis (“ rdeče oko ”), vznemirjenost, zaspanost, hoja v spanju, vedenjske težave, živčnost, zamašen nos ali izcedek iz nosa, kihanje, hitro dihanje, bleda ali pordela koža, podplutbe, velika občutljivost prstov na rokah in nogah na mraz, težave s kožo ali nohti, psoriaza (novonastala ali poslabšanje obstoječe), povečano potenje, večja potreba po odvajanju urina, drobni tresoči gibi, zmanjšana občutljivost za dotik, artritis.
Store in a refrigerator (2°C - 8°C).
439 Shranjujte v hladilniku (2 °C - 8 °C).
- The active substance is recombinant interferon alfa-2b, 5 million IU in a single dose vial
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 5 milijonov i. e. v viali z enkratnim
Nederland Walmolen 1 NL-3994 DL Houten Tel: + 31-(0)800 9999000
440 Nederland Danmark Walmolen 1 Lautrupbjerg 2 NL- 3994 DL Houten DK- 2750 Ballerup Tel: + 31 - (0) 800 9999000 Tlf: + 45- 44 39 50 00
Sverige Box 6185 S-102 33 Stockholm Tel: + 46-(0)8 522 21 500
441 Sverige Κύπρος Box 6185 Οδός Αγίου Νικολάου, 8 S- 102 33 Stockholm CY- 1055 Λευκωσία Tel: + 46 - (0) 8 522 21 500 Τηλ: +357- 22 757188
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/  426 HOW TO SELF INJECT INTRONA
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
INFORMATION FOR THE USER
443 NAVODILO ZA UPORABO
IntronA 10 million IU/ml solution for injection or infusion Interferon alfa-2b
IntronA 10 milijonov i. e. / ml raztopina za injiciranje ali infundiranje interferon alfa- 2b
 429 Using IntronA with food and drink While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
445 Uporaba zdravila IntronA skupaj s hrano in pijačo Medtem, ko prejemate zdravilo IntronA vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
 430 Multiple myeloma:
446 Multipli mielom:
4.
447 4.
 431 Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour (sometimes directed against others).
Nekateri bolniki postanejo med jemanjem zdravila IntronA samega ali v okviru kombiniranega zdravljenja z ribavirinom depresivni.
Very commonly reported side effects (at least 1 in every 10 patients): pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, stomach or abdominal pains, diarrhoea, nausea (feeling sick), viral infection, depression, emotional lability, insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
Zelo pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 10 bolnikov): bolečine, otekanje in pordelost ali poškodbe kože na mestu injiciranja, izpadanje las, omotica, sprememba teka, želodčne ali trebušne bolečine, driska, slabost (siljenje na bruhanje), virusne okužbe, depresija, čustvena nestabilnost, nespečnost, tesnoba, vnetje žrela in bolečine pri požiranju, utrujenost, mrzlica/ tresavica, zvišana telesna temperatura, gripi podobno stanje, splošni občutek neugodja, glavoboli, hujšanje, bruhanje, razdražljivost, šibkost, nihanje razpoloženja, kašelj (včasih hud), težko dihanje, srbenje, suha koža, izpuščaj, nenadne in hude mišične bolečine, sklepne bolečine, mišičnoskeletne bolečine, spremembe izvidov laboratorijskih krvnih preiskav vključno z 448 zmanjšanim številom belih krvničk.
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of  432 liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
Pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 100 bolnikov, vendar manj kot 1 na vsakih 10 bolnikov): žeja, dehidracija, zvišan krvni tlak, migrene, otekle bezgavke, pordelost, težave z menstruacijo, zmanjšana spolna sla, vaginalne težave, bolečine v dojkah, bolečine v modih, težave z žlezo ščitnico, pordele dlesni, suha usta, pordela ali vneta usta ali jezik, zobobol ali zobne bolezni, herpes simpleks (vročinske razjede), sprememba okusa, želodčne težave, dispepsija (zgaga), zaprtje, povečanje jeter (jetrne težave, včasih hude), vodeno blato, močenje postelje pri otrocih, vnetje sinusov, bronhitis, očesne bolečine, težave s solznimi kanalčki, konjunktivitis (“ rdeče oko ”), vznemirjenost, zaspanost, hoja v spanju, vedenjske težave, živčnost, zamašen nos ali izcedek iz nosa, kihanje, hitro dihanje, bleda ali pordela koža, podplutbe, velika občutljivost prstov na rokah in nogah na mraz, težave s kožo ali nohti, psoriaza (novonastala ali poslabšanje obstoječe), povečano potenje, večja potreba po odvajanju urina, drobni tresoči gibi, zmanjšana občutljivost za dotik, artritis.
Store in a refrigerator (2°C - 8°C).
449 Shranjujte v hladilniku (2 °C - 8 °C).
- The active substance is recombinant interferon alfa-2b, 10 million IU in a single dose vial
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 10 milijonov i. e. v viali z enkratnim
Nederland Walmolen 1 NL-3994 DL Houten Tel: + 31-(0)800 9999000
450 Nederland Danmark Walmolen 1 Lautrupbjerg 2 NL- 3994 DL Houten DK- 2750 Ballerup Tel: + 31 - (0) 800 9999000 Tlf: + 45- 44 39 50 00
Suomi/Finland PL 86/PB 86 FIN-02151 Espoo/Esbo Puh/Tel: + 358-(0)20-7570 300
Suomi/ Finland PL 86/ PB 86 FIN- 02151 Espoo/ Esbo
Κύπρος Οδός Αγίου Νικολάου, 8 CY-1055 Λευκωσία Τηλ: +357-22 757188
Palazzo Borromini I- 20090 Segrate (Milano) Tel: + 39- 02 21018. 1
Sverige Box 6185 S-102 33 Stockholm Tel: + 46-(0)8 522 21 500
451 Sverige Κύπρος Box 6185 Οδός Αγίου Νικολάου, 8 S- 102 33 Stockholm CY- 1055 Λευκωσία Tel: + 46 - (0) 8 522 21 500 Τηλ: +357- 22 757188
 435 HOW TO SELF INJECT INTRONA
452 KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA
INFORMATION FOR THE USER
453 NAVODILO ZA UPORABO
IntronA 18 million IU/3 ml solution for injection or infusion Interferon alfa-2b
IntronA 18 milijonov i. e. / 3 ml., raztopina za injiciranje ali infundiranje interferon alfa- 2b
 438 Using IntronA with food and drink While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
455 Uporaba zdravila IntronA skupaj s hrano in pijačo Medtem, ko prejemate zdravilo IntronA vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
 439 Multiple myeloma:
456 Multipli mielom:
4.
457 4.
 440 Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour (sometimes directed against others).
Nekateri bolniki postanejo med jemanjem zdravila IntronA samega ali v okviru kombiniranega zdravljenja z ribavirinom depresivni.
Very commonly reported side effects (at least 1 in every 10 patients): pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, stomach or abdominal pains, diarrhoea, nausea (feeling sick), viral infection, depression, emotional lability, insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
Zelo pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 10 bolnikov): bolečine, otekanje in pordelost ali poškodbe kože na mestu injiciranja, izpadanje las, omotica, sprememba teka, želodčne ali trebušne bolečine, driska, slabost (siljenje na bruhanje), virusne okužbe, depresija, čustvena nestabilnost, nespečnost, tesnoba, vnetje žrela in bolečine pri požiranju, utrujenost, mrzlica/ tresavica, zvišana telesna temperatura, gripi podobno stanje, splošni občutek neugodja, glavoboli, hujšanje, bruhanje, razdražljivost, šibkost, nihanje razpoloženja, kašelj (včasih hud), težko dihanje, srbenje, suha koža, izpuščaj, nenadne in hude mišične bolečine, sklepne bolečine, mišičnoskeletne bolečine, spremembe izvidov laboratorijskih krvnih preiskav vključno z 458 zmanjšanim številom belih krvničk.
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of  441 liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
Pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 100 bolnikov, vendar manj kot 1 na vsakih 10 bolnikov): žeja, dehidracija, zvišan krvni tlak, migrene, otekle bezgavke, pordelost, težave z menstruacijo, zmanjšana spolna sla, vaginalne težave, bolečine v dojkah, bolečine v modih, težave z žlezo ščitnico, pordele dlesni, suha usta, pordela ali vneta usta ali jezik, zobobol ali zobne bolezni, herpes simpleks (vročinske razjede), sprememba okusa, želodčne težave, dispepsija (zgaga), zaprtje, povečanje jeter (jetrne težave, včasih hude), vodeno blato, močenje postelje pri otrocih, vnetje sinusov, bronhitis, očesne bolečine, težave s solznimi kanalčki, konjunktivitis (“ rdeče oko ”), vznemirjenost, zaspanost, hoja v spanju, vedenjske težave, živčnost, zamašen nos ali izcedek iz nosa, kihanje, hitro dihanje, bleda ali pordela koža, podplutbe, velika občutljivost prstov na rokah in nogah na mraz, težave s kožo ali nohti, psoriaza (novonastala ali poslabšanje obstoječe), povečano potenje, večja potreba po odvajanju urina, drobni tresoči gibi, zmanjšana občutljivost za dotik, artritis.
Periodontal (affecting gums) and dental disorders, altered mental status, loss of consciousness, acute hypersensitivity reactions including urticaria (hives), angioedema (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing), bronchoconstriction and anaphylaxis (a severe, whole-body allergic reaction)have been reported, but their frequency is unknown.
Poročali so tudi o periodontalni bolezni (prizadetost dlesni), zobnih boleznih, spremenjenem duševnem stanju, izgubi zavesti ter akutnih preobčutljivostnih reakcijah, vključno z urtikarijo (koprivnica), angioedemom (otekanje dlani, stopal, gležnjev, obraza, ustnic, ust ali žrela, ki lahko povzroči težave pri požiranju ali dihanju), bronhokonstrikcijo in anafilaksijo (huda alergijska reakcija po vsem telesu), vendar njihova pogostnost ni znana.
Store in a refrigerator (2°C - 8°C).
459 Shranjujte v hladilniku (2 °C - 8 °C).
Once opened, the product may be stored for a maximum of 28 days at 2ºC – 8ºC.
Po odpiranju lahko zdravilo shranjujete največ 28 dni pri temperaturi od 2 do 8ºC.
 442 What IntronA contains
Kaj vsebuje zdravilo IntronA
- The active substance is recombinant interferon alfa-2b, 18 million IU in a multiple dose vial
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 18 milijonov i. e. v viali z večimi
- One ml of solution contains 6 million IU of interferon alfa-2b
- En ml raztopine vsebuje 6 milijonov i. e. interferona alfa- 2b
IntronA is available in six different pack sizes:
IntronA je na voljo v šestih različnih velikostih pakiranja:
- Pack of 1 vial
- Pakiranje:
- Pack of 1 vial, 6 injection syringes, 6 injection needles and 12 cleansing swabs
1 viala, 6 injekcijskih brizg, 6 injekcijskih igel in 12 čistilniih tamponov
- Pack of 2 vials
2 viali
- Pack of 2 vials, 12 injection syringes, 12 injection needles and 24 cleansing swabs
2 viali, 12 injekcijskih brizg, 12 injekcijskih igel in 24 čistilnih tamponov
- Pack of 12 vials
12 vial
- Pack of 12 vials, 72 injection syringes, 72 injection needles and 144 cleansing swabs
12 vial, 72 injekcijskih brizg, 72 injekcijskih igel in 144 čistilnih tamponov
Malta 168 Christopher Street MT-VLT02 Valletta Tel: + 356-21 23 21 75
460 Malta Česká republika 168 Christopher Street Ke Štvanici 3 MT- VLT02 Valletta CZ- 186 00 Praha 8 Tel: + 356- 21 23 21 75 Tel: +420 221771250
Sverige Box 6185 S-102 33 Stockholm Tel: + 46-(0)8 522 21 500
461 Sverige Κύπρος Box 6185 Οδός Αγίου Νικολάου, 8 S- 102 33 Stockholm CY- 1055 Λευκωσία Tel: + 46 - (0) 8 522 21 500 Τηλ: +357- 22 757188
This leaflet was last approved on  444 Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
 445 HOW TO SELF INJECT INTRONA
462 KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA
Corresponding dose (million IU) using IntronA 18 million IU/3 ml solution for injection or infusion
Ustrezen odmerek (milijoni i. e.) uporabljenega zdravila IntronA 18 milijonov i. e. / 3 ml raztopina za injiciranje ali infundiranje
Examine the solution prior to administration: it should be clear and colourless.
Ne smete je uporabiti, če opazite
 446 Do not use if discolouration or particulate matter is present.
463 obarvanje ali delce v njej.
INFORMATION FOR THE USER
464 NAVODILO ZA UPORABO
IntronA 25 million IU/2.5 ml solution for injection or infusion Interferon alfa-2b
IntronA 25 milijonov i. e. / 2, 5 ml raztopina za injiciranje ali infundiranje interferon alfa- 2b
 449 Using IntronA with food and drink While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
466 Uporaba zdravila IntronA skupaj s hrano in pijačo Medtem, ko prejemate zdravilo IntronA vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
 450 Multiple myeloma:
467 Multipli mielom:
 451 Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour (sometimes directed against others).
468 Nekateri bolniki postanejo med jemanjem zdravila IntronA samega ali v okviru kombiniranega zdravljenja z ribavirinom depresivni.
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of  452 liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
469 žeja, dehidracija, zvišan krvni tlak, migrene, otekle bezgavke, pordelost, težave z menstruacijo, zmanjšana spolna sla, vaginalne težave, bolečine v dojkah, bolečine v modih, težave z žlezo ščitnico, pordele dlesni, suha usta, pordela ali vneta usta ali jezik, zobobol ali zobne bolezni, herpes simpleks (vročinske razjede), sprememba okusa, želodčne težave, dispepsija (zgaga), zaprtje, povečanje jeter (jetrne težave, včasih hude), vodeno blato, močenje postelje pri otrocih, vnetje sinusov, bronhitis, očesne bolečine, težave s solznimi kanalčki, konjunktivitis (“ rdeče oko ”), vznemirjenost, zaspanost, hoja v spanju, vedenjske težave, živčnost, zamašen nos ali izcedek iz nosa, kihanje, hitro dihanje, bleda ali pordela koža, podplutbe, velika občutljivost prstov na rokah in nogah na mraz, težave s kožo ali nohti, psoriaza (novonastala ali poslabšanje obstoječe), povečano potenje, večja potreba po odvajanju urina, drobni tresoči gibi, zmanjšana občutljivost za dotik, artritis.
Once opened, the product may be stored for a maximum of 28 days at 2ºC – 8ºC.
470 Po odpiranju lahko zdravilo shranjujete največ 28 dni pri temperaturi od 2 do 8ºC.
 453 What IntronA contains
Kaj vsebuje zdravilo IntronA
- The active substance is recombinant interferon alfa-2b, 25 million IU in a multiple dose vial
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 25 milijonov i. e. v viali z večimi
- One ml of solution contains 10 million IU of interferon alfa-2b
- En ml raztopine vsebuje 10 milijonov i. e. interferona alfa- 2b
Nederland Walmolen 1 NL-3994 DL Houten Tel: + 31-(0)800 9999000
471 Nederland Danmark Walmolen 1 Lautrupbjerg 2 NL- 3994 DL Houten DK- 2750 Ballerup Tel: + 31 - (0) 800 9999000 Tlf: + 45- 44 39 50 00
Sverige Box 6185 S-102 33 Stockholm Tel: + 46-(0)8 522 21 500
472 Sverige Κύπρος Box 6185 Οδός Αγίου Νικολάου, 8 S- 102 33 Stockholm CY- 1055 Λευκωσία Tel: + 46 - (0) 8 522 21 500 Τηλ: +357- 22 757188
This leaflet was last approved on  455 Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
 456 HOW TO SELF INJECT INTRONA
473 KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA
(million IU) using IntronA ml solution for injection or infusion
10
 457 Injecting the solution Select the injection site.
474 Injiciranje raztopine Izberite si mesto, kamor boste injicirali zdravilo.
INFORMATION FOR THE USER
475 NAVODILO ZA UPORABO
IntronA 18 million IU solution for injection, multidose pen Interferon alfa-2b
IntronA 18 milijonov i. e., raztopina za injiciranje, peresnik z večimi odmerki interferon alfa- 2b
 460 Using IntronA with food and drink While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
477 Uporaba zdravila IntronA skupaj s hrano in pijačo Medtem, ko prejemate zdravilo IntronA vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
 461 Multiple myeloma:
478 Multipli mielom:
 462 Paediatric Use:
479 Uporaba pri otrocih: